A Phase 1 Study, in Cystic Fibrosis Patients, of the Safety, Toxicity, and Biological Efficacy of a Single Administration of a Replication Deficient, Recombinant Adenovirus Carrying the cDNA of the Normal Cystic Fibrosis Transmembrane Conductance Regulator Gene in the Lung. National Institutes of Health, Bethesda, Maryland

Authors:
  • AJAri Jaffe
    Ari Jaffe
  • SBSteve Brody
    Steve Brody
  • AMAndrea Mastrangeli
    Andrea Mastrangeli
  • NMNoel G. McElvaney
    Noel G. McElvaney
  • MRMelissa Rosenfeld
    Melissa Rosenfeld
  • CCChin-Shyan Chu
    Chin-Shyan Chu
  • CDClaire Danel
    Claire Danel
  • JHJohn Hay
    John Hay
  • TETony Eissa
    Tony Eissa

Abstract
No abstract available